UNSPSC 51402402: Prazitone

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DZB018428. European Medicines Agency schedules Prazitone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10009MIG. Prazitone generally arises in the molecular formula C16H19N3O3. The term PRAZITONE is an International Non-Proprietary Name or INN. PRAZITONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule prazitone under HS 29335400 and SITC kg. As of Q4 2014, PRAZITONE remains the US FDA Preferred Term for this commodity. Prazitone bears US NLM identifiers UMLS ID C1882439 and NCI Concept Code C66460. SMILES: O=C1NC(=O)NC(=O)C1(CC1NCCCC1)c1ccccc1.

UNSPSC 51402402 Prazitone is a Commodity code that describes pharmaceutical products, but recent state and local solicitations under this code show minimal specific activity tied to prazitone itself. The three opportunities posted since early 2026 instead reflect broader pharmaceutical and drug-management procurement: Seminole County, Florida seeking naloxone and drug deactivation systems; Texas Health and Human Services Commission conducting market research on direct-to-manufacturer prescription programs; and Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) establishing contracts for generic multi-source pharmaceuticals and over-the-counter products. State agencies, county health departments, and cooperative purchasing vehicles are the primary issuing bodies active under related pharmaceutical codes, with procurement ranging from specific emergency-response medications to broad generic pharmaceutical supply agreements.

Activity under pharmaceutical commodities spans Florida, Texas, Minnesota, and participating cooperative states including Oregon. Seminole County posted IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with bids due July 26, 2023. Texas HHS issued RFI HHS0017013 on April 3, 2026, to explore vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. MMCAP posted RFP S1070000015802 on January 20, 2026, with a March 26, 2026, response deadline, seeking generic pharmaceuticals and OTC products to be distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026. The code itself shows limited prazitone-specific procurement; vendors pursuing pharmaceutical contracts should track broader generic drug supply, emergency-response medication, and pharmacy benefit management initiatives across state and local health departments and cooperative purchasing platforms.